文献速递创伤与烧伤

含银泡沫敷料治疗部分厚度烧伤的系统评价

A systematic review of foam dressings for partial thickness burns.
PubMed 文献 · Am J Emerg Med · 2019-04-11
一句话结论中等质量证据显示含银泡沫敷料与磺胺嘧啶银纱布在部分厚度烧伤愈合上无显著差异,但泡沫敷料在早期换药时疼痛更轻。

该系统评价比较含银泡沫敷料与传统磺胺嘧啶银(SSD)加纱布敷料对部分厚度烧伤(体表面积<25%)伤口愈合的影响。检索877篇文献后纳入3项随机对照试验共346例患者(2项儿童与成人联合试验,1项成人试验)。中等质量证据显示两组在伤口再上皮化方面无显著差异,相对危险度的95%CI均跨1;泡沫敷料组在第7天首次换药时疼痛评分更优,但28天治疗结束时两组无显著差异;愈合时间相似,感染率数据不一致但倾向于泡沫敷料组。

要点

  • 中等质量证据:含银泡沫敷料与SSD纱布在部分厚度烧伤(<25%体表面积)的完全愈合率上无显著差异,所有试验的相对危险度95%CI均跨1。
  • 泡沫敷料组在第7天首次换药时疼痛评分更优,但第28天治疗结束时两组疼痛评分无显著差异。
  • 三项试验中愈合时间相似,无统计学差异。
  • 感染率倾向于泡沫敷料组,但数据不一致。
  • 纳入3项RCT共346例患者,排除头面会阴部烧伤、伤后≥36小时、非热力烧伤及免疫抑制患者。

适用人群与场景

  • 部分厚度热力烧伤、体表面积<25%的患者,纳入2项儿童与成人联合试验和1项成人试验。
  • 排除烧伤涉及头、面、会阴部者;烧伤时间≥36小时者;非热力烧伤者;免疫抑制患者。

研究设计与关键结果

  • 系统评价纳入3项随机对照试验,共346例患者(2项儿童与成人联合试验,1项成人试验),均比较含银泡沫敷料与磺胺嘧啶银加纱布敷料。
  • 主要结局完全愈合:中等质量证据显示两组伤口再上皮化无显著差异,三项试验的相对危险度95%CI均跨1。
  • 疼痛评分:泡沫敷料组在第7天首次换药时更优,但第28天治疗结束时两组无显著差异。
  • 愈合时间:三项试验相似,无统计学差异。
  • 感染率:倾向于泡沫敷料组,但数据不一致。

证据类型、等级与局限

  • 证据类型:系统评价,纳入3项随机对照试验,采用GRADE标准评估质量。
  • 证据质量:中等质量证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于部分厚度热力烧伤(体表面积<25%、非头面会阴部、伤后<36小时、非免疫抑制)患者,中等质量证据显示含银泡沫敷料与SSD纱布在伤口愈合上无显著差异。
  • 含银泡沫敷料可能减少早期换药时的疼痛,并可能降低感染率,但感染率数据不一致。

指南或共识出处

  • 原文为系统评价,未引用具体指南或共识。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Partial thickness burns are the most common form of thermal burns. Traditionally, dressing for these burns is simple gauze with silver sulfadiazine (SSD) changed on a daily basis. Foam dressings have been proposed to offer the advantage of requiring less frequent dressing change and better absorption of exudates.

OBJECTIVE: To compare the impact of silver-containing foam dressing to traditional SSD with gauze dressing on wound healing of partial thickness burns.

METHODS: We performed a systematic literature search using PubMed, EMBASE, CINAHL, Web of Science, Cochrane Library database and Google Scholar for trials comparing traditional SSD dressings to that of silver-containing foam dressing on wound healing in partial thickness burns <25% of the body surface area. We excluded studies that enrolled burns involving head, face, and genitals; burns older than or equal to 36 h, non-thermal burns, and immunocompromised patients. Quality of trials was assessed using the GRADE criteria. The main outcome, complete wound healing, is reported as percentages of wound with complete epithelialization after the follow up period. Relative risks of complete healing are also reported with respective 95% CI. Time to healing and pain score before, during, and after dressing change at each follow up visit are compared between the groups (means with standard deviation or medians with quartiles).

RESULTS: We identified a total of 877 references, of which three randomized controlled trials (2 combined pediatric and adult trials and 1 adult trial) with a total of 346 patients met our inclusion criteria. All three trials compared silver-containing foam dressing to SSD and gauze on partial thickness burns. Moderate quality evidence indicated no significant difference in wound re-epithelialization between the groups across all three trials as confidence intervals for the relative risks all crossed 1. Although pain scores favored foam dressing at the first dressing change (7 days), there was no significant difference between the groups at the end of the treatment period at 28 days. Time to wound healing was also similar across the three trials with no statistical difference. Infection rates favored the foam-dressing group, but data were inconsistent.

CONCLUSION: Moderate quality evidence indicates that there is no significant difference in wound healing between silver-containing foam dressing and SSD dressing. However, foam has the added benefit of reduced pain during the early treatment phase and potentially decreased infection rates.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chaganti P, Gordon I, Chao JH, et al. A systematic review of foam dressings for partial thickness burns. Am J Emerg Med. 2019. PMID: 31000315. doi:10.1016/j.ajem.2019.04.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。